The National Comprehensive Cancer Network, American Cancer Society Cancer Action Network, and the National Minority Quality Forum established three key areas of policy focus as part of the Alliance for Cancer Care Equity joint collaboration, including advancing diversity in clinical trials, improving cancer screening and early detection, and increasing access to patient navigation.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
